Dr. Bettina Lickiss

Business Development Manager

Germany

Research Interests

innoVitro is a CRO screening company for cardiac risk evaluation of new drugs for preclinical safety, tox and drug discovery purposes using the 2.5D FLEXcyte technology. We are interested in networking opportunities to drive OOAC awareness and its importance for drug development.